Frank McCormick discusses how each protein is a problem in the use of pharmaceutics to combat cancer and suggests that developing a platform that can be used for anything is the process that will alter the future of cancer treatment. (September 16, 2008)

Pharmacogenomics of Cancer

Anthony Oro, MD, PhD, discusses how Hedgehog signally is a model for a variety of morphogenetic signals, that taking stem cells to effect wound healing may have an important role in pathogenesis. (September 16, 2008)

Hedgehog Signaling and Cancer: New Concepts and Therapeutic Opportunities

Dr. Saul Rosenberg discusses the history of diagnosis and treatment of Hodgkin's Disease and the remarkable improvement in curability since the 1960's. (September 15, 2008)

Hodgkin's Disease: A Paradigm for Clinical Research

Stanford's Branimir Sikic discusses the importance of, and offers guidance to achieve the development of personalized medicines that are risk adapted genomic guided therapies which make a major impact on the disease. (September 15, 2008)

Targeted Anticancer Therapies

Dr. Michael Cleary discusses this work on the role of chromosomal aberrations in causing cancer and its implications for cancer treatment. (September 18, 2008)

Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer

Dr. John K. Chan, gyncecologic cancer specialist at the University of California - San Francisco Medical Center, discusses recent advances in the study of gynecologic cancers, focusing on novel therapeutics in ovarian cancer. (September 18, 2009)

Gynecologic Cancers: Translational Research Opportunities

Dr. Linda M. Boxer discusses her research on acute leukemia. (September 18, 2008)

Translational Research in Acute Leukemia

Dr. James Brooks discusses his work on screening for and treatment of prostate cancer. (September 18, 2008)

Translational Cancer Research in Urological Malignancies

Professor Christopher Contag discusses immune cell trafficking patterns as they relate to recognition of minimal residual disease. (September 16, 2008)

Imaging of Immune Cell Trafficking Patterns Refines Development of Cell-Based Therapies

Dr. James Ford, Associate Professor of Medicine and Genetics at the Stanford University School of Medicine, discusses possibilities for using genetic testing to predict and manage the risks of certain cancers. (September 17, 2008)

Assessing Genetic Risk for Cancer: Stanford Clinical Cancer Genetics Program

Comprehensive Cancer Research Training Program

Michael Clearly lectures on abnormal nuclear contants in cancer cells and chromosomal aberrations. (September 19, 2007)

Cancer Biology

Quynh-Thu Le lectures on translation research in radiotherapy and goes into detain on hypoxia metastasis, vascular normalization, and EGFR targeting. (September 18, 2007)

Translation Research in Radiotherapy

Hanlee Ji lectures on high throughput technologies for sequencing cancer genomes and gives people an opportunity to apply the research. (September 18, 2007)

High TP Gene Analysis

Dr. David Magnus discusses responsible conduct of research and informed consent, the two pillars of research ethics. (September 21, 2007)

The Ethical Conduct of Research

Frank Stockdale lectures on publishing scientific results and the importance of scientific writings. (September 19, 2007)

How to Publish Scientific Results

Dr. Garry Gold discusses the goals and uses of imaging in the medical field. (September 20, 2007)

Anatomic Human Imaging

Dee West lectures on the history and benefits of the NCCC. (September 18, 2007)

The NCCC Research Resource

Dr. Alan Garber discusses decision and cost-effective analysis in relation to health care. (September 20, 2007)

Decision Analysis: Outcomes Research

Sandra Horning discusses and defines investigator research trials. (September 20, 2007)

The Investigator Initiated Research Trial

Beverly Mitchell lectures on Leukemia. (September 19, 2007)

Signal Transduction: Leukemia

Dr. Sylvia Plevritis discusses how mathematics can be used to help in cancer screening and the proportion of deaths that are prevented by screening. (September 20, 2007)

Mathematical Models of Cancer Screening Outcomes

Garrison Fathman answers whether adoptive cellular gene therapy will overcome the risks of conventional gene therapy. (September 19, 2007)

The Academic Research Laboratory - Industry Interaction

Paul Yock lectures on the process of translating discoveries and local resources. (September 19, 2007)

Life Science Technology Transfer: Overview and Local Resources

Philip Beachy lectures on hedgehog pathway, the development signaling pathways, and neoplastic growth. (September 19, 2007)

Hedgehog Pathway

Dr. Linda Boxer discusses genetic mutations and how they can potentially activate oncogenes. (September 21, 2007)

Oncogenes and Cancer

Dr. David Spiegel discusses the emotional and psychological stressors of fighting cancer and other diseases. (September 21, 2008)

Psychosocial Research with Cancer Patients

The best podcast episodes on global issues affecting everyone. Covering topics such as the #metoo movement, climate change, the impact of technology and some of the biggest global issues facing us right now. For anyone interested in learning more about the world, and some of the issues we're facing, pick an episode below and start listening! Add episodes you're interested into your queue below!

Best Episodes on Global Issues

The best podcast episodes on physical health. Episodes talk about your diet, sleep, exercise and all the things that people do to improve their physical health and live a healthier life. This topic is for everyone, with applications in all of our everyday lives. Add episodes you're interested into your queue below!